Search results
Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports First...
WKRN Nashville· 5 days agoNuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, ...
BMO raises CytomX shares target on Phase 1 data By Investing.com
Investing.com· 5 days agoCytomX Therapeutics, which specializes in developing cancer treatments, shared data indicating a...
Astellas Showcases Scientific Advancements Across its Oncology Portfolio at 2024 ASCO Annual Meeting
WPRI Providence· 22 hours agoAstellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") will share new research from across its innovative portfolio of approved and investigational cancer< ...
AI aids analysis of lifetime environmental exposures
Medical Xpress· 14 hours agoMost human diseases are fueled by both genetic and environmentalfactors. Untangling these external influences and how they intersect with our genes could...
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 days agoJazz Pharmaceuticals plc (NASDAQ:JAZZ) Q1 2024 Earnings Call Transcript May 1, 2024 Jazz...
American Cancer Society Launches Largest-ever Study to Probe Disparities in Cancer Outcomes for...
Skanner· 4 days agoThe American Cancer Society is embarking on an unprecedented initiative spanning 20 states, including the District of Columbia, Maryland, and Virginia, to investigate the ...
The relationship between elevated cholesterol levels and heart attack
Rolling Out· 2 days agoLet's delve deeper into the relationship between elevated cholesterol and heart attack risk.
AMERICAN ACADEMY OF DERMATOLOGY SURVEY SHOWS OUTDOOR WORKERS MORE AT RISK FOR SKIN CANCER THAN...
The Parsons Sun· 7 days agoIn recognition of Skin Cancer Awareness Month this May, the AAD encourages everyone – and especially those who work outdoors – to practice safe sun to protect themselves from ...
Five common sweeteners and what they’re really doing to your body
The Telegraph via Yahoo News· 5 days agoOver the last five to six years, a new sweetener has found its way into a variety of common foods....
Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
Morningstar· 5 days agoKite, a Gilead Company (NASDAQ: GILD), and Arcellx, Inc. (NASDAQ: ACLX) today announced several key operational updates on their partnered anitocabtagene autoleucel (anito-cel) multiple myeloma ...